Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Codex DNA Q2 EPS $(0.50) Beats $(0.51) Estimate, Sales $5.66M Beat $4.45M Estimate

Author: Michael Horton | August 09, 2022 04:22pm
Codex DNA (NASDAQ:DNAY) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.51) by 1.96 percent. This is a 52.83 percent increase over losses of $(1.06) per share from the same period last year. The company reported quarterly sales of $5.66 million which beat the analyst consensus estimate of $4.45 million by 27.08 percent. This is a 98.28 percent increase over sales of $2.85 million the same period last year.

Posted In: DNAY


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist